JPWO1992001393A1 - Functional food composition using licorice extract - Google Patents

Functional food composition using licorice extract

Info

Publication number
JPWO1992001393A1
JPWO1992001393A1 JP3-512848A JP51284891A JPWO1992001393A1 JP WO1992001393 A1 JPWO1992001393 A1 JP WO1992001393A1 JP 51284891 A JP51284891 A JP 51284891A JP WO1992001393 A1 JPWO1992001393 A1 JP WO1992001393A1
Authority
JP
Japan
Prior art keywords
functional food
food composition
lactic acid
weight
licorice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3-512848A
Other languages
Japanese (ja)
Other versions
JP2801964B2 (en
Inventor
利夫 佐藤
仁 松本
新納 靖規
寿夫 掛川
徳太郎 三木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Hypox Laboratories Inc
Original Assignee
Nippon Hypox Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Hypox Laboratories Inc filed Critical Nippon Hypox Laboratories Inc
Priority to JP3512848A priority Critical patent/JP2801964B2/en
Priority claimed from JP3512848A external-priority patent/JP2801964B2/en
Publication of JPWO1992001393A1 publication Critical patent/JPWO1992001393A1/en
Application granted granted Critical
Publication of JP2801964B2 publication Critical patent/JP2801964B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Abstract] This publication contains application data prior to electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 甘草抽出物を用いた機能性食茄用組成物技術分野 本発明は機能性食品用組成物および機能性食品に係り、特に、甘草抽出物を用い た機能性食品用組成物および機能性食品に関する。[Detailed Description of the Invention] Functional Food Compositions Using Licorice Extract Technical Field The present invention relates to functional food compositions and functional foods, and more particularly to functional food compositions and functional foods using licorice extract.

背景技術 日本薬局方に記載されている甘草(g17c7rrhixi ;Nationa l Fotmular7. E −0ツバ薬局方ではLiquirilitia e Radix )は、古くから食品の調味や薬用として用いられてきた。特に 、主成分であるグリチルリチンはしょ糖の150倍の甘さがあり、甘味料として 現在でも広(用いられている。BACKGROUND ART Licorice (g17c7rrhixi; Liquorice Radix in the National Pharmacopoeia 7.E-0 and the Taiwan Pharmacopoeia 7.E-0) has long been used as a food seasoning and medicinal ingredient. In particular, its main component, glycyrrhizin, is 150 times sweeter than sucrose and is still widely used today as a sweetener.

その一方で、甘草抽出物には抗潰瘍作用(Takagi。On the other hand, licorice extract has antiulcer activity (Takagi.

K、、 l5hii、Y、 :Arxein Forsch、17.1544( 1967))や肝障害保護作用等の薬理作用があることが知られている。K,, l5hii,Y,: Arxein Forsch, 17.1544 (1967)) and is known to have pharmacological effects such as protecting against liver damage.

しかしながら甘草抽出物は、グリチルリチンが比較的多量に含まれていることか ら、甘味が極めて強い。However, licorice extract contains a relatively large amount of glycyrrhizin, which gives it an extremely sweet taste.

このため、甘草抽出物を食品用組成物として用いる場合には、嗜好性の面から、 その使用方法および使用量が限定されてしまい、甘草抽出物が有する保健予防効 果および保健治療効果を十分に活用することが極めて困難であった。For this reason, when licorice extract is used in food compositions, its use method and amount are limited due to palatability considerations, making it extremely difficult to fully utilize the health preventive and therapeutic effects of licorice extract.

したがって本発明の第1の目的は、甘草抽出物が有する保健予防効果および保健 治療効果を十分に活用することができ、かつ食し易い機能性食品用組成物を提供 することにある。Therefore, the first object of the present invention is to provide a functional food composition that can fully utilize the preventive and therapeutic health effects of licorice extract and is easy to consume.

また、本発明の第2の目的は、甘草抽出物が有する保健予防効果および保健治療 効果を十分に活用することができ、かつ食し易い機能性食品を提供することにあ る。A second object of the present invention is to provide a functional food that can fully utilize the preventive and therapeutic health effects of licorice extract and is easy to eat.

発明の開示 本発明者等は、甘草抽出物に特定の処理を施すことにより、甘草が元来もつ保健 予防効果および保健治療効果を十分に活用することができ、かつ食し易い機能性 食品用組成物が得られることを見出し、本発明を完成するに至った。Disclosure of the Invention The inventors discovered that by subjecting licorice extract to specific processing, it is possible to fully utilize the preventive and therapeutic health benefits inherent in licorice and obtain an easy-to-eat functional food composition, leading to the completion of the present invention.

すなわち、上記第1の目的を達成する本発明の機能性食品用組成物は、せ軍属( G17c7rrhixa属)植物から得られる抽出物を乳酸醗酵させてなること を特徴とするものである。That is, the functional food composition of the present invention, which achieves the first object described above, is characterized by being obtained by subjecting an extract obtained from a plant of the genus G17c7rrhixa to lactic acid fermentation.

また、上記第2の目的を達成する本発明の機能性食品は、上述した本発明の機能 性食品用組成物を含有することを特徴とするものである。Furthermore, the functional food of the present invention, which achieves the second object, is characterized by containing the functional food composition of the present invention.

図面の簡単な説明 第1図は本発明の機能性食品用組成物の可視部および紫外部の吸収スペクトルの 一例を示す図、第2図は本発明の機能性食品用組成物の可視部および紫外部の吸 収スペクトルの他の一例を示す図である。BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 shows an example of the visible and ultraviolet absorption spectra of the functional food composition of the present invention, and Figure 2 shows another example of the visible and ultraviolet absorption spectra of the functional food composition of the present invention.

発明を実施するための最良の形態 本発明の機能性食品用組成物は、前述のように、せ草属(G17cHrhixa 属)植物から得られる抽出物を原料として用いる。この抽出物としては、甘草水 抽出液が特に好ましい。ここで、甘草とは、従来より甘味料、賦形剤、漢方薬等 に利用されている甘草を意味し、例えば下記の植物が例示される。BEST MODE FOR CARRYING OUT THE INVENTION As mentioned above, the functional food composition of the present invention uses as its raw material an extract obtained from a plant of the genus G17cHrhixa. As this extract, licorice water extract is particularly preferred. Here, "licorice" refers to licorice that has traditionally been used as a sweetener, excipient, herbal medicine, etc., and includes, for example, the following plants:

・溝用甘草 (G17cyrrhiza uralenis Fisch、el DC,)・ 光果甘草 (G、gl!bra Linnり ・スペイン甘草 (G、glabra L va+、j7pica Reg、tl l1erd) ・ロシア甘草 (G、glabra L var、glandulilCra RB、el 1 lerd)・ベルジャ甘草 (Goglabra L var、violacea Boiss、)これらの 甘草を用いた甘草水抽出液は、甘草に1〜1000倍量(W/W)の水を加え、 5〜140℃で0.1〜72時間加熱抽出処理することにより得られる。甘草水 抽出液を得るにあたっては、生の甘草をそまま利用することも可能であるが、甘 草の乾燥物を利用することが特に好ましい。生の甘草またはその乾燥物は、全軍 であっても、全草の一部(根、ストロン等)であってもよいが、特に、皮を除去 した根の乾燥物や皮を除去したストロンの乾燥物が好ましい。乾燥物を用いる場 合は、粉末として使用することが好ましい。・Gutter Licorice (G17cyrrhiza uralenis Fisch, el DC,) Light Fruit Licorice (G, gl!bra Linnli ・Spanish Licorice (G, glabra L va+, j7pica Reg, tl l erd) ・Russian Licorice (G, glabra L var, glandulil Cra RB, el l erd) ・Berja Licorice (G, glabra L var, violacea Boiss,) These licorice water extracts are made by adding 1 to 100g of licorice root extract. This is obtained by adding 1000 times the amount (w/w) of water and heating and extracting at 5 to 140°C for 0.1 to 72 hours. Fresh licorice can be used as is to obtain the extract, but dried licorice is particularly preferred. The fresh licorice or its dried form may be the whole plant or a part of the whole plant (root, stolons, etc.), with dried roots with the bark removed and dried stolons with the bark removed being particularly preferred. When using dried material, it is preferable to use it as a powder.

また、甘草水抽出液として、従来より漢方薬に利用されている甘草エキスを1〜 1000倍M1(w/w)の水に溶解させた液や、甘草粗エキスを1〜1000 倍fi(w/w)の水に懸濁させた液を用いてもよい。本発明では、これらの液 も甘草水抽出液という。Alternatively, the aqueous licorice extract may be prepared by dissolving licorice extract, which has traditionally been used in herbal medicines, in 1 to 1,000 times the concentration (w/w) of water, or by suspending crude licorice extract in 1 to 1,000 times the concentration (w/w) of water. In the present invention, these solutions are also referred to as aqueous licorice extracts.

本発明の機能性食品用組成物は、前述したように、せ軍属(Glycyrrhi xa属)植物から得られる抽出物を乳酸醗酵させてなる。抽出物として上述の甘 草水抽出液を用いた場合、本発明の機能性食品用組成物は、この甘草水抽出液を 乳酸醗酵させて得た醗酵液(以下、この醗酵液を機能性食品用組成物Iというこ とがある)からなる。また、本発明の機能性食品用組成物は、上記醗酵液中の水 分を除去して得た半固形ないし固形の物質(以下、この物質を機能性食品用組成 物11ということがある)からなっていてもよい。As described above, the functional food composition of the present invention is prepared by lactic acid fermentation of an extract obtained from a plant of the genus Glycyrrhixa. When the above-described aqueous licorice extract is used as the extract, the functional food composition of the present invention comprises a fermented liquid obtained by lactic acid fermentation of the aqueous licorice extract (hereinafter, this fermented liquid may be referred to as functional food composition I). The functional food composition of the present invention may also comprise a semi-solid or solid substance obtained by removing the water from the fermented liquid (hereinafter, this substance may be referred to as functional food composition 11).

上記甘草水抽出液を乳酸醗酵させるにあたって用いる菌としては、従来より乳製 品等を得るために利用されている乳酸菌をそのまま用いることができるが、特に 、ラクトバシルス(LaCfobacillus )属またはビフィドバクテリ ウム(BiliIiojauuivm )属の乳酸菌が好ましい。これらの属の 乳酸菌は各々単独で使用してもよいし、併用してもよい。また、これらの乳酸菌 として、ヨーグルト等の乳製品に含まれる乳酸菌をこの乳製品とともに使用して もよい。The bacteria used to lactic acid ferment the licorice water extract can be any lactic acid bacteria conventionally used to produce dairy products, but lactic acid bacteria of the genera Lactobacillus (Lactobacillus) or Bifidobacterium (Bifidobacterium) are particularly preferred. These lactic acid bacteria may be used alone or in combination. Furthermore, lactic acid bacteria contained in dairy products such as yogurt may also be used in conjunction with the dairy product.

甘草水抽出液の乳酸醗酵は、甘草水抽出液と、乳酸菌または乳酸菌を含む乳製品 とを混在させて、1〜40℃の通性嫌気的状態の下に1日〜1年放置することに より行うことができる。このとき、乳酸菌の栄養源として寒天培地等を必要に応 じて混在させてもよい。Lactic acid fermentation of licorice water extract can be carried out by mixing the licorice water extract with lactic acid bacteria or a dairy product containing lactic acid bacteria and leaving it to stand for one day to one year under facultative anaerobic conditions at 1 to 40°C. If necessary, agar medium or the like may be mixed in as a nutrient source for the lactic acid bacteria.

乳酸菌として、乳製品に含まれる乳酸菌をこの乳製品とともに使用した場合には 、この乳製品が乳酸菌の栄養源となるので、他の栄養源は混在させなくてもよい 。When lactic acid bacteria contained in dairy products are used together with the dairy product, the dairy product serves as a nutrient source for the lactic acid bacteria, so no other nutrient source is required.

この乳酸醗酵は、醗酵液中に含まれるイソリクイリチン(甘草由来の成分)、乳 酸(乳酸菌の代謝生産物)およびグリチルリチン(甘草由来の成分)の量が、イ ソリクイリチン1重量部に対して乳酸16〜500重量部、グリチルリチン1/ 3〜30重屋部となるように行うことが好ましい。甘草水抽出液に含まれていた イソリクイリチンおよびグリチルリチンは、この甘草水抽出液が乳酸醗酵される ことに伴って量的に低下する。また、醗酵液中の乳酸の量は、一般に、醗酵期間 を長くするに従って増加する。This lactic acid fermentation is preferably carried out so that the amounts of isoliquiritin (a licorice-derived component), lactic acid (a metabolic product of lactic acid bacteria), and glycyrrhizin (a licorice-derived component) contained in the fermentation liquor are 16 to 500 parts by weight of lactic acid and 1/3 to 30 parts by weight of glycyrrhizin per 1 part by weight of isoliquiritin. The amounts of isoliquiritin and glycyrrhizin contained in the licorice aqueous extract decrease as the licorice aqueous extract undergoes lactic acid fermentation. Furthermore, the amount of lactic acid in the fermentation liquor generally increases with increasing fermentation period.

イソリクイリチン1重量部に対する乳酸の量が16重量部未満では、グリチルリ チンの量に対する乳酸の量も少ないことから、醗酵液は極めて甘く、食し難い。If the amount of lactic acid per part by weight of isoliquiritin is less than 16 parts by weight, the amount of lactic acid relative to the amount of glycyrrhizin is also small, so the fermented liquid is extremely sweet and difficult to eat.

また、イソリクイリチン1重量部に対する乳酸の量が500重量部を超えると、 グリチルリチンの量に対する乳酸の量も多いことから、醗酵液は極めて酸っばく なり、食し難い。醗酵液中のグリチルリチンの量は、イソリクイリチン1重量部 に対して14重量部以下、特に10重量部以下が好ましい。Furthermore, if the amount of lactic acid per part by weight of isoliquiritin exceeds 500 parts by weight, the ratio of lactic acid to glycyrrhizin will be too high, making the fermented liquid extremely sour and inedible. The amount of glycyrrhizin in the fermented liquid should preferably be 14 parts by weight or less, and especially 10 parts by weight or less, per part by weight of isoliquiritin.

甘草水抽出液を上述のようにして乳酸醗酵させることにより得られる本発明の機 能性食品用組成物Iは、下記a −h a 上述のようにして得た乳酸醗酵液そのもの(以下、醗酵液Aということがあ る)、 b 醗酵液Aに、食品の製造過程において通常行われる滅菌処置、特に好ましく は加熱滅菌を施したもの(以下、醗酵液Bということがある)、C醗酵液Aに含 まれる不溶物を濾過または遠心分離により除いた液(以下、醗酵液Cということ がある)、 d 醗酵液Bに含まれる不溶物を濾過または遠心分離により除いた液(以下、醗 酵液りということがある)、 e 醗酵液Cに、食品の製造過程において通常行われる滅菌処置、特に好ましく は加熱滅菌を施したもの(以下、醗酵液Eということがある)、f 醗酵液A1 醗酵液B1醗酵液C1醗酵液りおよび醗酵液Eからなる群より選択された少なく とも2種の醗酵液を混合させた液(以下、醗酵液Fということがある)、 g 醗酵液A〜醗酵液Fのいずれかの醗酵液の濃縮液(以下、醗酵液Gといとい うことがある)のいずれの醗酵液からなっていてもよい。本発明では、これらを 総称して、甘草水抽出液を乳酸醗酵させて得た醗酵液という。The functional food composition I of the present invention, obtained by lactic acid fermentation of licorice water extract as described above, can be prepared from the following: a) the lactic acid fermentation broth itself obtained as described above (hereinafter, sometimes referred to as fermentation broth A); b) fermentation broth A subjected to a sterilization treatment commonly performed in food manufacturing, particularly heat sterilization (hereinafter, sometimes referred to as fermentation broth B); c) the liquid obtained by removing insoluble matter contained in fermentation broth A by filtration or centrifugation (hereinafter, sometimes referred to as fermentation broth C); d) the liquid obtained by removing insoluble matter contained in fermentation broth B by filtration or centrifugation (hereinafter, sometimes referred to as fermentation broth C). The fermented liquid may consist of any of the following fermented liquids: (a) Fermented liquid C obtained by lactic acid fermentation (hereinafter referred to as "fermented liquid C"); (b) Fermented liquid C obtained by sterilization, preferably heat sterilization, as commonly performed in food manufacturing processes; (c) Fermented liquid A1, (d) Fermented liquid B1, (e) Fermented liquid C obtained by sterilization, preferably heat sterilization; (f) Fermented liquid A2, (f) Fermented liquid B1, (f) Fermented liquid C1, (g) Fermented liquid E2, or (h) Fermented liquid F3; (g) Fermented liquid A4, (f) Fermented liquid B5, (f) Fermented liquid C6, (f) Fermented liquid E4, or (h) Fermented liquid G5. In the present invention, these fermented liquids are collectively referred to as "fermented liquids obtained by lactic acid fermentation of licorice water extract."

これらの醗酵液A〜醗酵液Gのいずれの醗酵液中にも、イソリクイリチン1重量 部に対して16〜500重量部の乳酸および1/3〜30重量部のグリチルリチ ンが含有されている。また、これらの醗酵液はいずれも、265〜275nm付 近および305〜320nm付近に紫外部吸収を示す。そして、これらの醗酵液 の5 w / v%水溶液はいずれも、メタノール、エタノールまたはアセトン を加えたときに白色の沈澱を生じる。Each of these fermentation broths, Fermentation Broth A through Fermentation Broth G, contains 16 to 500 parts by weight of lactic acid and 1/3 to 30 parts by weight of glycyrrhizin per part by weight of isoliquiritin. Furthermore, each of these fermentation broths exhibits ultraviolet absorption around 265 to 275 nm and 305 to 320 nm. Furthermore, 5% w/v aqueous solutions of these fermentation broths produce a white precipitate when methanol, ethanol, or acetone is added.

一方、本発明の機能性食品用組成物11は、前述したように、甘草水抽出液を乳 酸醗酵させた後の醗酵液(上述の機能性食品用組成物■)に含まれる水分を除去 して得た半固形ないし固形の物質からなる。機能性食品用組成物Iに含まれる水 分の除去は、減圧濃縮処理や凍結乾燥処理等の常法により行うことができる。On the other hand, functional food composition 11 of the present invention is a semi-solid or solid substance obtained by removing the water contained in the fermentation liquid (the functional food composition 1 described above) obtained after lactic acid fermentation of licorice water extract, as described above. The water contained in functional food composition 1 can be removed by conventional methods such as vacuum concentration or freeze-drying.

この機能性食品用組成物11中にも、イソリクイリチン1重量部に対して16〜 500重量部の乳酸および1/3〜30重量部のグリチルリチンが含有されてい る。また、この機能性食品用組成物11の水溶液は265〜27Snm付近およ び305〜32Onm付近に紫外部吸収を示す。そして、この機能性食品用組成 物IIの5 w / v%水溶液は、メタノール、エタノールまたはアセトンを 加えたときに白色の沈澱を生じる。This functional food composition 11 also contains 16 to 500 parts by weight of lactic acid and 1/3 to 30 parts by weight of glycyrrhizin per part by weight of isoliquiritin. Furthermore, an aqueous solution of this functional food composition 11 exhibits ultraviolet absorption near 265 to 27 S nm and near 305 to 32 O nm. Furthermore, a 5 wt % aqueous solution of this functional food composition II produces a white precipitate when methanol, ethanol, or acetone is added.

なお、本発明の機能性食品用組成物■および機能性食品用組成物11はいずれも 、一般に、以下の様な生物学的特性を示す。In addition, both functional food composition 1 and functional food composition 11 of the present invention generally exhibit the following biological properties:

・微生物試験 大腸菌群 陰性 黄色ブドウ球菌 陰性 緑膿菌 陰性 このようにしてなる本発明の機能性食品用組成物Iおよび機能性食品用組成物1 1はいずれも、肝保護作用、抗潰瘍作用、脂質過酸化抑制作用等の薬理活性を有 する。そして、これらの薬理活性は、一般に、乳酸醗酵前の甘草水抽出液よりも 強い。したがって、本発明の機能性食品用組成物(機能性食品用組成物Iおよび /または機能性食品用組成物11)をそのまま、または他の食品に添加して食す ることにより、甘草が元来もつ保健予防効果および保健治療効果を十分に活用す ることができる。また、本発明の機能性食品用組成物には適度の酸味があり、甘 草が元来有する持続性の強い甘味はほとんど感じられない。このため、本発明の 機能性食品用組成物は味見的にも食し易い。また、他の食品に添加した場合でも 食し易い機能性食品が得られる。Microbiological Testing Coliform: Negative Staphylococcus aureus: Negative Pseudomonas aeruginosa: Negative Both of the functional food compositions I and 11 of the present invention thus obtained possess pharmacological activities, including hepatoprotective, antiulcer, and lipid peroxidation inhibitory effects. These pharmacological activities are generally stronger than those of licorice aqueous extracts prior to lactic acid fermentation. Therefore, by consuming the functional food compositions of the present invention (functional food compositions I and/or 11) directly or by adding them to other foods, the inherent health preventive and therapeutic benefits of licorice can be fully utilized. Furthermore, the functional food compositions of the present invention have a moderate sourness, with the long-lasting sweetness inherent to licorice barely noticeable. Therefore, the functional food compositions of the present invention are palatable. Furthermore, when added to other foods, they produce functional foods that are easy to eat.

次に、本発明の機能性食品について説明する。Next, the functional food of the present invention will be described.

本発明の機能性食品は、上述した本発明の機能性食品用組成物を含有した食品か らなる。ベースとなる食品は特に限定されるものではな(、水、清涼飲料や果実 飲料等のドリンク類、菓子類、パン類、麺類、調味料等、種々の食品をベースと することができる。The functional food of the present invention comprises a food containing the functional food composition of the present invention. The base food is not particularly limited, and various foods can be used as the base food, such as water, soft drinks, fruit drinks, confectioneries, breads, noodles, and seasonings.

本発明の機能性食品は、ベースとなる食品の製造工程に上述した本発明の機能性 食品用組成物を添加する工程を加えることにより、あるいは、ベースとなる食品 の製造後に上述した本発明の機能性食品用組成物を添加する工程を加えることに より、容易に得ることができる。このとき、必要に応じて矯味矯臭剤を添加して もよい。The functional food of the present invention can be easily obtained by adding the above-described functional food composition of the present invention to the production process of a base food, or by adding the above-described functional food composition of the present invention after the production of the base food. At this time, a flavoring agent may be added, if necessary.

本発明の機能性食品における上述した機能性食品用組成物の含有量は、目的とす る機能性食品の種類や好み等により異なるが、甘草が元来もつ保健予防効果およ び保健治療効果を十分に活用するうえから0.1重量%以上にすることが好まし い。The content of the functional food composition in the functional food of the present invention varies depending on the type of functional food desired and personal preference, but is preferably 0.1% by weight or more in order to fully utilize the inherent health-promoting and health-treating effects of licorice.

このようにして得られる本発明の機能性食品は、本発明の機能性食品用組成物を 含有していることから、甘草が元来もつ保健予防効果および保健治療効果を十分 に活用し得る食品である。また、味覚的にも食し易いものである。The functional food of the present invention thus obtained contains the functional food composition of the present invention, and is therefore a food that can fully utilize the preventive and therapeutic health effects inherent to licorice. Furthermore, it is also palatable.

以下、本発明の機能性食品用組成物および機能性食品について、それぞれ実施例 を挙げて説明する。The functional food composition and functional food of the present invention will be described below with reference to examples.

実施例1(機能性食品用組成物■の製造)局方せ草末(皮除去)20gを水11 に加え、約90℃にて1時間加熱抽出した。冷却後、せ草末を含んだままの抽出 液に、乳酸菌として森永ビヒダス[森永乳業(株)製のヨーグルトの商品名コに 含まれる乳酸菌をこのヨーグルトとともに加え、ガラス容器に移して密栓をした 後、このガラス容器を転置して、通性嫌気状態にした。Example 1 (Preparation of Functional Food Composition 1) 20 g of Pharmacopoeia japonica powder (husk removed) was added to 1 liter of water and heated for 1 hour at approximately 90°C for extraction. After cooling, the extract still containing the japonica powder was added with lactic acid bacteria contained in Morinaga Bifidus (product name of yogurt manufactured by Morinaga Milk Industry Co., Ltd.) along with the yogurt. The mixture was transferred to a glass container, sealed, and then inverted to create a facultative anaerobic environment.

この後、室温にて2週間、時に容器全体を振盪する以外は放置して、乳酸醗酵さ せた。Thereafter, the mixture was left to stand at room temperature for 2 weeks, occasionally shaking the entire container, to allow lactic acid fermentation to occur.

2週間後、ガラス容器の内容物を取り出して吸引濾過し、得られた濾液を90℃ にて90分間加熱滅菌して、本発明の機能性食品用組成物I約0.9βを得た。After two weeks, the contents of the glass container were removed and filtered under suction. The resulting filtrate was sterilized by heating at 90°C for 90 minutes to obtain approximately 0.9β of functional food composition I of the present invention.

得られた機能性食品用組成物■の組成を、下記の条件の下に高速液体クロマトグ ラフィーにより分析したところ、この機能性食品用組成物■は少なくとも20成 分からなることが明らかとなった。The composition of the functional food composition (II) obtained was analyzed by high performance liquid chromatography under the conditions described below, and it was found that the functional food composition (II) consisted of at least 20 components.

・カラム: Cosmosil 5C1g [商品名、ナカライティスク(株) 製コ ・移動相:メタノールと水の混液(容量比で、メタノール:水=60:40)を リン酸でpH2゜1に調整した液 ・流速:1.5ml/分 ・検出器:紫外可視分光光度計 (検出波長:250nm) なお、上記条件の下に高速液体クロマトグラフィーにより分析した各成分のピー ク保持時間および含有量を、表1に示す。Column: Cosmosil 5C 1g [product name, manufactured by Nacalai Tisque, Inc.] Mobile phase: A mixture of methanol and water (methanol:water = 60:40 by volume) adjusted to pH 2.1 with phosphoric acid Flow rate: 1.5 ml/min Detector: UV-Visible spectrophotometer (Detection wavelength: 250 nm) Table 1 shows the peak retention times and contents of each component analyzed by high-performance liquid chromatography under the above conditions.

また、得られた機能性食品用組成物の可視部および紫外部の吸収スペクトルを、 図1に示す。The visible and ultraviolet absorption spectra of the obtained functional food composition are shown in Figure 1.

比較例1 森永ビヒダス[森永乳業(株)製のヨーグルトの商品名]に含まれる乳酸菌をこ のヨーグルトとともに加えなかった以外は実施例1と同様にして、組成物(甘草 抽出物)を得た。Comparative Example 1: A composition (licorice extract) was obtained in the same manner as in Example 1, except that the lactic acid bacteria contained in Morinaga Bifidus (the trade name of yogurt manufactured by Morinaga Milk Industry Co., Ltd.) was not added along with the yogurt.

得られた組成物の組成を、実施例1と同じ条件の下に高速液体クロマトグラフィ ーにより分析したところ、この組成物は少なくとも22成分からなることが明ら かとなった。The composition of the resulting composition was analyzed by high performance liquid chromatography under the same conditions as in Example 1, and it was found to consist of at least 22 components.

なお、高速液体クロマトグラフィーにより分析した各成分のピーク保持時間およ び含有量を、表2に示す。The peak retention time and content of each component analyzed by high performance liquid chromatography are shown in Table 2.

(以下余白) 表1と表2との比較から明らかなように、実施例1で得られた本発明の機能性食 品用組成物1においては、グリチルリチン(表1におけるピークナンバー19の 成分および表2におけるピークナンバー20の成分)の含有jli(相対値)が 115以下に減少している一方で、ピーク保持時間で2分以内の成分が増加して いる。(Blank space follows) As is clear from a comparison of Tables 1 and 2, in the functional food composition 1 of the present invention obtained in Example 1, the relative content of glycyrrhizin (the component corresponding to peak number 19 in Table 1 and peak number 20 in Table 2) decreased to 115 or less, while the content of components with peak retention times of 2 minutes or less increased.

実施例2〜実施例4(機能性食品用組成物■の製造)本発明の機能性食品用組成 物を、以下の要領でそれぞれ製造した。Examples 2 to 4 (Preparation of Functional Food Compositions 1) The functional food compositions of the present invention were prepared in the following manner.

まず、局方せ草末30gを蒸留水1p中に懸濁し、約70℃にて2時間加熱抽出 した。室温にまで冷却した後、せ草末を含んだままの抽出液に、乳酸菌とし、て 森永ビヒダス[森永乳業(株)製のヨーグルトの商品名]に含まれる乳酸菌をこ のヨーグルト200gとともに無菌操作の下に加え、ガラス容器に移して密栓を した後、このガラス容器を転置して、通性嫌気状態にした。First, 30 g of Pharmacopoeia serrata powder was suspended in 1 pf distilled water and heated for 2 hours at approximately 70°C for extraction. After cooling to room temperature, the extract still containing the serrata powder was mixed with 200 g of yogurt containing lactic acid bacteria, Morinaga Bifidus (the trade name of yogurt manufactured by Morinaga Milk Industry Co., Ltd.), under aseptic conditions. The mixture was then transferred to a glass container, sealed, and then inverted to create a facultative anaerobic environment.

次いで、30〜35℃で3日間、時に容器全体を振盪する以外は放置して、乳酸 醗酵させた。The mixture was then left to undergo lactic acid fermentation at 30-35°C for 3 days, with occasional shaking of the entire vessel.

3日後、ガラス容器の内容物(乳酸醗酵液)を煮沸して醗酵を止め、放冷し室温 にまで冷却した後に遠心分離した。遠心分離後に上清を分取して、本発明の機能 性食品用組成物■約0.8βをそれぞれ得た。After three days, the contents of the glass containers (lactic acid fermentation broth) were boiled to stop the fermentation, allowed to cool to room temperature, and then centrifuged. After centrifugation, the supernatant was separated to obtain approximately 0.8β of the functional food composition of the present invention.

各実施例で得られた機能性食品用組成物の組成を表3に示す。また、比較として 、局方せ草末30gを蒸留水1j2中に懸濁し、約70°Cにて2時間加熱抽出 し−て得た甘草抽出液の組成も、表3に示す。The composition of the functional food composition obtained in each Example is shown in Table 3. For comparison, the composition of a licorice extract obtained by suspending 30 g of licorice powder in 1/2 liter of distilled water and extracting by heating at approximately 70°C for 2 hours is also shown in Table 3.

表3から明らかなように、各機能性食品用組成物Iには、イソリクイリチン1重 量部に対して乳酸が16〜500重量部の範囲内で含有されているとともに、イ ソリクイリチン1重量部に対してグリチルリチンが1/3〜30重量部の範囲内 で含有されている。これに対して比較どして挙げた甘草抽出液では、乳酸は通常 検出されないか、または表3に示したように、その含有量は極めて低い。As is clear from Table 3, each functional food composition I contains 16 to 500 parts by weight of lactic acid per part by weight of isoliquiritin, and 1/3 to 30 parts by weight of glycyrrhizin per part by weight of isoliquiritin. In contrast, in the licorice extracts listed for comparison, lactic acid is usually not detectable or, as shown in Table 3, its content is extremely low.

また、各機能性食品用組成物Iを5人の成人男子に賞味してもらったところ、実 施例2〜実施例3て得られた各機能性食品用組成物Iについては5人全員から甘 くないとの回答を得た。また、実施例4で得られた機能性食品用組成物Iについ ては5人中4人から甘くないとの回答を得た。Furthermore, when five adult males were asked to taste each functional food composition I, all five subjects answered that the functional food compositions I obtained in Examples 2 and 3 were not sweet. Furthermore, four out of the five subjects answered that the functional food composition I obtained in Example 4 was not sweet.

また、各機能性食品用組成物Iをそれぞれ水で25倍に希釈し、これらの希釈液 の可視部および紫外部の吸収スペクトルを実施例1と同様にして測定したところ 、いずれの機能性食品用組成物■でも、265〜275nm付近および305〜 320nn+付近に紫外部吸収が認められた。これらの測定結果のうち、実施例 2で得られた機能性食品用組成物Iの可視部および紫外部の吸収スペクトルを図 2に示す。In addition, each functional food composition I was diluted 25-fold with water, and the visible and ultraviolet absorption spectra of these diluted solutions were measured in the same manner as in Example 1. For each functional food composition I, ultraviolet absorption was observed near 265-275 nm and near 305-320 nm. Among these measurement results, the visible and ultraviolet absorption spectra of functional food composition I obtained in Example 2 are shown in Figure 2.

さらに、各機能性食品用組成物Iについて、それぞれ5 w / v%水溶液を 調製し、これらの水溶液にメタノールを5倍量加えたところ、いずれの水溶液で も白色の沈澱が生じた。白色の沈澱は、メタノールに代えてエタノールを加えた 場合でも、またアセトンを加えた場合でも、それぞれ生じた。Furthermore, 5 w/v% aqueous solutions of each functional food composition I were prepared, and when five times the amount of methanol was added to these solutions, a white precipitate formed in all of the solutions. The white precipitate also formed when ethanol or acetone was added instead of methanol.

実施例5(機能性食品用組成物■の製造)局方せ草末(皮除去)40gと寒天培 地5gとを水11に加え、70℃にて2時間加熱抽出した。冷却後、せ草末およ び寒天培地を含んだままの抽出液に、乳酸菌としてラクトハシルス ブルガリク ス(LaclobgCillu+ bu1garic+++)を加え、以下、実 施例]と同様にして、本発明の機能性食品用組成物!約0゜9Ilを得た。Example 5 (Preparation of Functional Food Composition 1) 40 g of Pharmacopoeia serrata powder (husk removed) and 5 g of agar medium were added to 1 L of water and extracted by heating at 70°C for 2 hours. After cooling, Lactobacillus bulgaricus (Lactobacillus bulgaricus +++) was added as a lactic acid bacterium to the extract solution still containing the serrata powder and agar medium, and approximately 0.9 L of the functional food composition of the present invention was obtained in the same manner as in the Examples.

実施例6(機能性食品用組成物■の製造)局方せ草末(皮除去)20gとヨーグ ルト[商品名。Example 6 (Production of Functional Food Composition 1) 20 g of Pharmacopoeia serrata powder (husk removed) and yogurt [trade name .

明治ブルガリアヨーグルト、明治乳業(株)製]5gとを水1ぶに加え、70℃ にて2時間加熱抽出した。5 g of Meiji Bulgaria Yogurt (manufactured by Meiji Dairies Co., Ltd.) was added to 1 part water and extracted by heating at 70°C for 2 hours.

冷却後、せ草末およびヨーグルトを含んだままの抽出液に、乳酸菌としてビフィ ドバクテリウム ロンガン(flilidobacle+iom longum )を加え、以下、実施例j、と同様にして、本発明の機能性食品用組成物I約0 ゜9Ilを得た。After cooling, Bifidobacterium longum (lactic acid bacteria) was added to the extract containing the watercress powder and yogurt, and the procedure was repeated as in Example J to obtain approximately 0.9 l of functional food composition I of the present invention.

実施例7(機能性食品用組成物Iの製造)スペイン甘草の全草乾燥物100gを 細切して水1βに加え、70℃にて2時間加熱抽出した。冷却後、スペイン甘草 の細切物を含んだままの抽出液に、乳酸菌としてラクトバシルス カセイ (Laclobacillus casei )を加え、以下、実施例1と同様 にして、本発明の機能性食品用組成物I約0. 9kを得た。Example 7 (Preparation of Functional Food Composition I) 100 g of dried Spanish licorice whole plant was shredded and added to 1/4 of water, followed by heating and extraction at 70°C for 2 hours. After cooling, Lactobacillus casei was added as a lactic acid bacterium to the extract still containing the shredded Spanish licorice. The procedure was repeated as in Example 1 to obtain approximately 0.9 kg of functional food composition I of the present invention.

実施例8〜実施例10(機能性食品用組成物11の製造)実施例2〜実施例4で 得られた各機能性食品用組成物Iをそれぞれ凍結乾燥させて、9.5〜15.8 gの固形物(機能性食品用組成物11)を得た。Examples 8 to 10 (Preparation of Functional Food Composition 11) Each of the functional food compositions I obtained in Examples 2 to 4 was freeze-dried to obtain 9.5 to 15.8 g of a solid (functional food composition 11).

各機能性食品用組成物11について、それぞれ水溶液を調製し、各水溶液の可視 部および紫外部の吸収スペクトルを実施例1と同様にして測定したところ、いず れの水溶液でも、265〜275nm付近および305〜320nm付近に紫外 部吸収が認められた。Aqueous solutions were prepared for each of the functional food compositions 11, and the visible and ultraviolet absorption spectra of each solution were measured in the same manner as in Example 1. In all of the solutions, ultraviolet absorption was observed in the vicinity of 265 to 275 nm and 305 to 320 nm.

また、各機能性食品用組成物11について、それぞれ5 w 、/ v%水溶液 を調製し、これらの水溶液にメタノールを5倍量加えたところ、いずれの水溶液 でも白色の沈澱が生じた。白色の沈澱は、メタノールに代えてエタノールを加え た場合でも、またアセトンを加えた場合でも、それぞれ生じた。Furthermore, 5 w/v% aqueous solutions of each functional food composition 11 were prepared, and when five times the amount of methanol was added to these solutions, a white precipitate formed in all of the solutions. The white precipitate also formed when ethanol or acetone was added instead of methanol.

実施例1】 (機能性食品用組成物11の製造)実施例7で得られた機能性食品 用組成物Iを減圧濃縮して、軟エキス(機能性食品用組成物1t)20gを得た 。Example 1 (Production of Functional Food Composition 11) Functional Food Composition I obtained in Example 7 was concentrated under reduced pressure to obtain 20 g of a soft extract (Functional Food Composition 1t).

この軟エキスの水溶液を調製し、この水溶液の可視部および紫外部の吸収スペク トルを実施例1と同様にして測定したところ、265〜275nm付近および3 05〜32Onm付近に紫外部吸収が認められた。An aqueous solution of this soft extract was prepared, and the visible and ultraviolet absorption spectra of this aqueous solution were measured in the same manner as in Example 1. As a result, ultraviolet absorption was observed in the vicinity of 265 to 275 nm and 305 to 320 nm.

また、この軟エキスの5 w/V%水溶液を調製し、この水溶液にメタノールを 5倍量加えたところ、白色の沈澱が生じた。白色の沈澱は、メタノールに代えて エタノールを加えた場合でも、またアセトンを加えた場合でも、それぞれ生じた 。Furthermore, when a 5% w/v aqueous solution of this soft extract was prepared and five times the amount of methanol was added to this solution, a white precipitate formed. This white precipitate also formed when ethanol or acetone was added instead of methanol.

薬理試験1(四塩化炭素肝障害に対する作用)肝保護作用を検定するのに確立さ れた方法である、四塩化炭素による急性肝障害モデルマウスを用いた検定法[ト キシコロジー アンド アプライド ファーマコロジ−(Toxicol、Ap pi Pharmacc+1.) 67.159(1983)]に準じで、本発 明の機能性食品用組成物Iか有する肝保護作用を以下の要領で検定した。Pharmacological Test 1 (Effect on Carbon Tetrachloride-Induced Liver Damage) The hepatoprotective effect of functional food composition I of the present invention was tested in the following manner using a mouse model of acute liver damage caused by carbon tetrachloride, an established method for testing hepatoprotective effects [Toxicol. Applied Pharmacology, Vol. 67, No. 159 (1983)].

まず、体重か30g前後のICR系雄性マウスを23個体用意し、1群4〜5個 体として5群に分けた。First, 23 male ICR mice weighing approximately 30 g were prepared and divided into 5 groups, each consisting of 4 to 5 mice.

次いで、5群のうちの1群(4個体)は対照群として、各個体の背部皮下に、オ リーブ油と四塩化炭素とを容量比で10:1の割合で含有する混合物を体重]O gあたり0.1.mlの割合で投与して急性肝炎を発症させた。そして、投与直 後、投与12時間後および48時間後にそれぞれ、1個体あたり0. 5mlの 生理食塩液を経口投与し、3回目の生理食塩液投与の48時間後に屠殺して採血 し、常法により血清中のGOT(グルタミン酸オキサロ酢酸アミノ基転移酵素) 量およびG、FT(グルタミン酸ピルビン酸アミノ基転移酵素)量を測定した。Next, one of the five groups (four animals) served as a control group. Each animal was subcutaneously administered a mixture of olive oil and carbon tetrachloride (volume ratio: 10:1) at a dose of 0.1 ml per 10 g of body weight to induce acute hepatitis. Immediately, 12 hours, and 48 hours after administration, each animal was orally administered 0.5 ml of saline. Forty-eight hours after the third saline administration, the animals were sacrificed and blood samples were collected. Serum GOT (glutamate oxaloacetate aminotransferase) and GFT (glutamate pyruvate aminotransferase) levels were measured using standard methods.

また残りの4群は、実施例1で得られた機能性食品用組成物Iを投与する群(実 施例群1.5個体)、実施例5で得られた機能性食品用組成物Iを投与する群( 実施例群2.4個体)、実施例6で得られた機能性食品用組成物Iを投与するi (実施例群3.5個体)、および比較例1で得られた組成物(甘草水抽出液)を 投与する群(比較例群1.5個体)に分けた。そして、これらの群の個体につい ては、それでれ対照群と同様にして急性肝炎を発症させた後に、生理食塩液に代 えて各実施例で得られた機能性食品用組成物■または比較例]で得られた組成物 を経口投与し、他は対照271と同様にして、血清中のGOTfltおよびGP TJ51を測定した。The remaining four groups were divided into a group administered functional food composition I obtained in Example 1 (Example group 1.5 individuals), a group administered functional food composition I obtained in Example 5 (Example group 2.4 individuals), a group administered functional food composition I obtained in Example 6 (Example group 3.5 individuals), and a group administered the composition obtained in Comparative Example 1 (aqueous licorice extract) (Comparative example group 1.5 individuals). After acute hepatitis was induced in these groups in the same manner as in the control group, the functional food composition obtained in each Example or the composition obtained in the Comparative example was orally administered instead of saline. Serum GOTflt and GP TJ51 were measured in the same manner as in control group 2.

これらの結果を、表4に示す。The results are shown in Table 4.

表4から明らジ・1なように、実施例1、実施例5および実施例6で得られた各 機能性食品用組成物■を投与した実施例群1〜実施例群3では、対照群に比べて GOT量およびGPTltが有意に少なく、がっ甘草水抽出液を投与した比較例 群1のGOTJIおよびGl)Tffiよりも少ない。As can be seen from Table 4, in Example Groups 1 to 3, which were administered the functional food compositions obtained in Examples 1, 5, and 6, the GOT and GPTlt levels were significantly lower than in the control group, and were also lower than the GOTJI and GPTffi levels in Comparative Example Group 1, which was administered licorice water extract.

このことから、本発明の機能性食品用組成物1の肝保護作用は甘草水抽出液の肝 保護作用よりも強いことがわかる。This indicates that the hepatoprotective effect of the functional food composition 1 of the present invention is stronger than that of the aqueous licorice extract.

四塩化炭素の肝毒性の一部は、生体内で生じるCCI 3ラジカルによる脂質過 酸化反応に由来することが明らかとなっている。そこで、本発明の機能性食品用 組成物1がCCl4により誘発される脂質過酸化反応を抑制するか否かを、以下 の薬理試験2で調べた。It has been shown that part of the hepatotoxicity of carbon tetrachloride is due to lipid peroxidation caused by the CCl3 radical generated in vivo. Therefore, the following pharmacological test 2 was conducted to examine whether functional food composition 1 of the present invention inhibits lipid peroxidation induced by CCl4.

薬理試験2(脂質過酸化反応に対する抗酸化作用)検体溶液として、実施例2で 得られた機能性食品用組成物■と、実施例2と同様にして得た甘草水抽出液に実 施例2と同様にしてヨーグルトを加えただけのもの(以下、醗酵0日液というこ とがある)と、イソリクイリチンのアルコール溶液とを用い、これらの検体溶液 について、以下の要領で抗酸化作用試験を行った。Pharmacological Test 2 (Antioxidant Effect on Lipid Peroxidation) The test solutions used were the functional food composition II obtained in Example 2, a licorice water extract obtained in the same manner as in Example 2 to which yogurt was added in the same manner as in Example 2 (hereinafter sometimes referred to as the "0-day fermentation solution"), and an alcohol solution of isoliquiritin. Antioxidant activity tests were conducted on these test solutions as follows.

まず、ラット肝ミクロゾームを常法により得た後に1.15%KCIに懸濁して 、タンパク質を2mg/mlの割合で含有するミクロゾーム懸濁液を得た。First, rat liver microsomes were obtained by a conventional method and then suspended in 1.15% KCl to obtain a microsome suspension containing 2 mg/ml of protein.

次いで、トリス−T(Clバッファ500μmにこのミクロゾーム懸濁液100 μmと、N A D P 11生成系水溶液(30+nMのG−6−Pと、51 U/+nlのG−6−Pデヒドロゲナーゼと、3.2 mMのNΔDPと、8Q mMのニコチンアミドを含有)200μmと、10%DMF水溶液で表5に示す 濃度に調整した検体溶液100μmとを加え、37℃で5分間加温した。Next, 100 μM of this microsome suspension was added to 500 μM Tris-T (Cl) buffer, 200 μM of an aqueous solution of NAD P 11 generating system (containing 30 nM G-6-P, 51 U/nL G-6-P dehydrogenase, 3.2 mM NAD P, and 8 mM nicotinamide), and 100 μM of a sample solution adjusted to the concentration shown in Table 5 with 10% DMF aqueous solution, and the mixture was heated at 37°C for 5 minutes.

次に、四塩化炭素(100mM10v/v%D M SO溶液)100μmを加 えて37°Cで20分間加温し、水冷により反応を停止した後、反応液1mlに ついて、チオバルビッール酸法により過酸化脂質の生成量を測定した。検体溶液 の抗酸化作用はブランクと比較し、阻害率(%)で表した。Next, 100 μM of carbon tetrachloride (100 mM, 10% v/v DMSO solution) was added and heated at 37°C for 20 minutes. The reaction was stopped by cooling with water, and the amount of lipid peroxide produced was measured using the thiobarbituric acid method for 1 ml of the reaction mixture. The antioxidant activity of the sample solution was expressed as a percentage inhibition compared with the blank.

なおブランクでは、検体溶液に代えて10%I) M P100μmを、またN  A D P H生成゛系水溶液200μ[に代えて水100μIを、モして四 塩化炭素(100mM’l Ov/v%DMso溶液)100μii:、代えT l0V/V%DMSO溶液100μlをそれぞれ加えた。For the blank, 100 μl of 10% DMSO solution was added instead of the sample solution, 100 μl of water was added instead of 200 μl of the NADPH generating aqueous solution, and 100 μl of carbon tetrachloride (100 mM 100% v/v DMSO solution) was added instead of 100 μl of 10% v/v DMSO solution.

結果を表5に示す。The results are shown in Table 5.

表5から明らかなように、検体溶液の濃度が同じである場合には、機能性食品用 組成物lを投与した群の脂質過酸化反応阻害率の方が、醗酵0日液を投与した群 の脂質過酸化反応阻害率よりも高い。As is clear from Table 5, when the concentrations of the test solutions were the same, the lipid peroxidation inhibition rate in the group administered functional food composition 1 was higher than that in the group administered the 0-day fermentation solution.

このことから、本発明の機能性食品用組成物■の抗酸化作用は醗酵0日液の抗酸 化作用よりも強いことがわかる。そしてこの結果からも、先の薬理試験1で示し たように、本発明の機能性食品用組成物Iが肝保護作用を有していることがわか る。また、この肝保護作用の少なくとも一部は、本発明の機能性食品用組成物■ が有する抗酸化作用に基づくものであることがわかる。This indicates that the antioxidant effect of functional food composition II of the present invention is stronger than that of the fermentation solution on day 0. Furthermore, as shown in Pharmacological Test 1 above, these results also demonstrate that functional food composition I of the present invention has a hepatoprotective effect. Furthermore, it is clear that at least a portion of this hepatoprotective effect is due to the antioxidant effect of functional food composition II of the present invention.

薬理試験3(抗潰瘍作用) 実施例2で得られた機能性食品用組成物1と、実施例2と同様にして得た甘草水 抽出液に実施例2と同様にしてヨーグルトを加えただけのもの(以下、醗酵0日 液ということがある)とについて、塩酸−エタノール潰瘍に対する抗潰瘍作用を 以下の要領で試験した。Pharmacological Test 3 (Anti-ulcer Activity) The anti-ulcer activity of functional food composition 1 obtained in Example 2 and a licorice water extract obtained in the same manner as in Example 2, to which yogurt was simply added in the same manner as in Example 2 (hereinafter sometimes referred to as the 0-day fermentation solution), against hydrochloric acid-ethanol ulcers was tested as follows.

まず、体重が180〜220gのS I)系雄性ラット(5個体/群)を24時 間絶食させた後、150m1の塩酸を含有する60%エタノール溶液(塩酸−エ タノール溶液)を、体重100g当り0.51の用量で各個体に経口投与して、 塩酸−エタノール潰瘍を惹起させた。First, SI male rats (5 rats/group) weighing 180-220 g were fasted for 24 hours, and then a 60% ethanol solution containing 150 ml of hydrochloric acid (hydrochloric acid-ethanol solution) was orally administered to each rat at a dose of 0.5 l/100 g of body weight to induce hydrochloric acid-ethanol ulcers.

次に、塩酸−エタノール溶液の投与から1時間後に各個体をエーテル麻酔し、放 血屠殺してから胃を摘出した。そして、摘出した胃を固定した後に腺胃部に発生 した潰瘍の長さを測定し、各個体毎に発生した潰瘍の長さの総和をめて潰瘍係数 とした。One hour after administration of the hydrochloric acid-ethanol solution, each animal was anesthetized with ether, exsanguinated, and sacrificed, and the stomach was removed. The removed stomach was then fixed and the length of the ulcers that had developed in the glandular stomach was measured, and the sum of the lengths of the ulcers that had developed in each animal was calculated as the ulcer index.

なお、機能性食品用組成物■および醗酵0日液は、それぞれ減圧下に濃縮して1 7/4量としてから検体溶液として用い、これらの検0体溶液は、体18 ]、  OOg当りlnlの用量で、塩酸−エタノール溶液の投与の30分前に各個体 に経口投与した。またコントロールでは、検体溶液に代えて検体溶液と同用員の 蒸溜水を経口投与した 結果を表6に示す。The functional food composition 1 and the 0-day fermentation solution were each concentrated under reduced pressure to 1/7/4 volume and used as test solutions. These test solutions were orally administered to each individual at a dose of 1/100 of the total volume (18%), 30 minutes before the administration of the hydrochloric acid-ethanol solution. As a control, distilled water was orally administered in the same amount as the test solution instead of the test solution. The results are shown in Table 6.

表6から明らかなように、機能性食品用組成物■を投与した群の潰瘍係数は、醗 酵0日液を投与した群の潰瘍係数よりも小さい。As is clear from Table 6, the ulcer index of the group administered with functional food composition II was smaller than that of the group administered with the 0-day fermented liquid.

このことから、本発明の機能性食品用組成物■の抗潰瘍作用は醗酵0日液の抗潰 瘍作用よりも強いことがわかる。This indicates that the antiulcer effect of the functional food composition (2) of the present invention is stronger than that of the 0-day fermentation solution.

薬理試験4(90日間の亜急性毒性試験および30日間の回復試験) 実施例1で得られた本発明の機能性食品用組成物Iを、5週齢のウィスター系雄 ラットに10m1./個体の割合で90日間連続経口投与し、その後30日間の 回復試験を行った。Pharmacological Test 4 (90-Day Subacute Toxicity Test and 30-Day Recovery Test) The functional food composition I of the present invention obtained in Example 1 was orally administered to 5-week-old male Wistar rats at a rate of 10 ml/rat for 90 consecutive days, followed by a 30-day recovery test.

この結果、投与期間中および回復期間中のいずれにおいても、−膜状態、体重、 血液化学的検査、尿中電解質等のパラメーターに変化は認められなかった。As a result, no changes were observed in parameters such as membrane status, body weight, blood chemistry tests, or urinary electrolytes during either the administration or recovery period.

この結果より、本発明の機能性食品用組成物Iには毒性が無いことが明らかであ る。These results clearly demonstrate that the functional food composition I of the present invention is non-toxic.

パネルテスト 実施例1で得られた、本発明の機能性食品用組成物lを水で10倍に希釈して約 4℃に冷却したものを試験液とし、この試験液40m1を22〜55歳の成人男 子パネラ−10名に昼食前に飲用させて、飲用後に評価を聞いた。Panel Test The functional food composition of the present invention obtained in Example 1 was diluted 10-fold with water and cooled to approximately 4°C to prepare a test solution. 40 ml of this test solution was consumed by a panel of 10 adult males aged 22 to 55 before lunch, and the panelists were asked to evaluate the results after consumption.

パネラ−の評価は以下のものであった。ただし、復数の回答を認めた。The panelists' evaluations were as follows. However, multiple responses were allowed.

1、適度な酸味があり、うまいと感じた。 6名2、酸味が強く違和感を感じた 。 0名3、手足のだるさが消え快活感を感じた。 3名4、飲用後口中に清涼 感が残り、食欲が沸いた。1. It had a moderate acidity and tasted delicious. 6 people 2. The acidity was too strong and felt strange. 0 people 3. The fatigue in my limbs disappeared and I felt energized. 3 people 4. A refreshing feeling remained in my mouth after drinking it, and my appetite was stimulated.

4名 5、一時的に腹部膨満感を感じたが、その後すぐに食欲が沸いた。 1名 6、甘味を感じた。 0名 7、異臭を感じた。 0名 また、10名のパネラ−の中で二日酔いを訴えていた2名から、飲用後に二日酔 いによるむかつき、倦怠感が消えたとの中し出があった。4 people 5. I felt a temporary feeling of abdominal bloating, but my appetite returned shortly thereafter. 1 person 6. I tasted a sweet taste. 0 people 7. I noticed an odd odor. 0 people Furthermore, two of the 10 panelists who had complained of hangovers reported that their nausea and fatigue disappeared after drinking the beverage.

実施例12(機能性食品の製造) 実施例1で得られた機能性食品用組成物1を原材料の1つとして用いて、以下の 組成のソフトドリンク(本発明の機能性食品の1つ)1000ccを得た。Example 12 (Production of Functional Food) Using the functional food composition 1 obtained in Example 1 as one of the raw materials, 1000 cc of a soft drink (one of the functional foods of the present invention) with the following composition was prepared.

オレンジ果汁 17.5g グレープフルーツ果汁 14.0g パイナツプル果汁 4.2g 果糖、ブドウ糖、液糖(BXニア5) 140 gクエン酸 4.0g フレーバー 1.0g 機能性食品用組成物I 5.0g 精製水 残量 実施例13(機能性食品の製造) 実施例2で得られた機能性食品用組成物Iを原材料の1つとして用いて、以下の 組成の清涼飲料(本発明の機能性食品の1つ)を得た。Orange juice 17.5 g Grapefruit juice 14.0 g Pineapple juice 4.2 g Fructose, glucose, liquid sugar (BXNia 5) 140 g Citric acid 4.0 g Flavor 1.0 g Functional food composition I 5.0 g Purified water (balance) Example 13 (Production of functional food) Using functional food composition I obtained in Example 2 as one of the raw materials, a soft drink (one of the functional foods of the present invention) with the following composition was prepared.

精製水 38.70g 機能性食品用組成物I 58. 03g砂糖 2.90g クエン酸ナトリウム 0.07g L−アスコルビン酸 0.10g 塩化ナトリウム 0.05g クエン酸 0.1g 矯味剤 適量 フレーバー 適量 実施例14(機能性食品の製造) 実施例5で得られた機能性食品用組成物Iを原材料の1つとして用いて、以下の 組成の炭酸飲料(本発明の機能性食品の1つ)1000ccを得た。Purified water 38.70 g Functional food composition I 58.03 g Sugar 2.90 g Sodium citrate 0.07 g L-ascorbic acid 0.10 g Sodium chloride 0.05 g Citric acid 0.1 g Flavoring agent (as needed) Flavor (as needed) Example 14 (Production of a functional food) Using functional food composition I obtained in Example 5 as one of the raw materials, 1000 cc of a carbonated beverage (one of the functional foods of the present invention) with the following composition was prepared.

グラニユー糖 4.2g クエン酸 1.0g ビタミンC0,1g グレープスキンカラー 5.0g フレーバー 1.8g 機能性食品用組成物1 5.0g 炭酸水 残量 実施例15(機能性食品の製造) 実施例6で得られた機能性食品用組成物Iを原材料の1つとして用いて、以下の 組成のキャラメル(本発明の機能性食品の1つ)200gを得た。Granulated sugar 4.2 g Citric acid 1.0 g Vitamin C 0.1 g Grapeskin color 5.0 g Flavor 1.8 g Functional food composition 1 5.0 g Carbonated water (balance) Example 15 (Production of a functional food) Using functional food composition I obtained in Example 6 as one of the raw materials, 200 g of caramel (one of the functional foods of the present invention) having the following composition was obtained.

砂糖 70.0g 水飴 83. og 練乳 30. og 小麦粉 9. 38g 牛乳 18.75g バター 2.25g ヤシ油 0.75g 機能性食品用組成物I 5.0g 実施例16(機能性食品の製造) 実施例11と同様にして機能性食品用組成物11(軟エキス)を20.g得、こ の機能性食品用組成物11を原材料の1つとして用いて、以下の要領でクツキー (本発明の機能性食品の1つ)300gを得た。Sugar 70.0 g Starch syrup 83.0 g Condensed milk 30.0 g Wheat flour 9.38 g Milk 18.75 g Butter 2.25 g Coconut oil 0.75 g Functional food composition I 5.0 g Example 16 (Production of functional food) 20.0 g of functional food composition 11 (soft extract) was obtained in the same manner as in Example 11. Using this functional food composition 11 as one of the raw materials, 300 g of cookies (one of the functional foods of the present invention) were obtained as follows.

まず、得られた軟エキス(機能性食品用組成物I+)20gと砂糖100gとバ ター80gとを練合した後、卵黄1個、小麦粉200 g、および適量のバニラ エツセンスを加えてさらに練合した。First, 20 g of the obtained soft extract (functional food composition I+) was kneaded with 100 g of sugar and 80 g of butter, and then one egg yolk, 200 g of wheat flour, and an appropriate amount of vanilla extract were added and further kneaded.

得られた混合物を4℃にて一定時間放置した後、通常のクツキーの製法に従って 、機能性食品用組成物11を含有するクツキー300gを焼きあげた。The resulting mixture was left to stand at 4°C for a certain period of time, and then 300 g of cookies containing functional food composition 11 were baked according to a conventional cookie manufacturing method.

実施例17(機能性食品の製造) 実施例1で得られた機能性食品用組成物■を原材料の1つとして用い、この機能 性食品用組成物■を含量が1重量%となるようにウドンの原材料に添加した後、 通常のうどんの製法に従ってウドン(本発明の機能性食品の1つ)を得た。Example 17 (Production of Functional Food) The functional food composition II obtained in Example 1 was used as one of the ingredients. Functional food composition II was added to the udon ingredients at a content of 1% by weight. Udon noodles (one of the functional foods of the present invention) were then obtained according to a standard udon noodle production method.

実施例12〜実施例17で得られた各機能性食品をそれぞれ5人の成人男子に賞 味してもらったところ、いずれの機能性食品についても、味覚的にも食べ易いと の回答を得た。The functional foods obtained in Examples 12 to 17 were tasted by five adult males, and all of the functional foods were found to be easy to eat and tasty.

以上説明したように、本発明の機能性食品用組成物は、乳酸醗酵前の甘草水抽出 液よりも強い肝保護作用、抗潰瘍作用、脂質過酸化抑制作用等の薬理活性を有し ている。そして本発明の機能性食品用組成物は、そのままでも、また本発明の機 能性食品としても食し易い。As described above, the functional food composition of the present invention has stronger pharmacological activities, such as hepatoprotective activity, antiulcer activity, and lipid peroxidation inhibitory activity, than the aqueous licorice extract before lactic acid fermentation. Furthermore, the functional food composition of the present invention is easy to eat either as is or as a functional food of the present invention.

したがって本発明によれば、甘草が元来もつ保健予防効果および保健治療効果を 容易に、かつ十分に活用することが可能となる。Therefore, according to the present invention, it is possible to easily and fully utilize the preventive and therapeutic health effects inherent to licorice.

Claims (1)

【特許請求の範囲】 1.甘草属(Glycyrrhiza属)植物から得られる抽出物を乳酸醗酵さ せてなることを特徴とする機能性食品用組成物。 2.甘草水抽出液を乳酸醗酵させて得た醗酵液からなり、イソリクイリチン1重 量部に対して16〜500重量部の乳酸および1/3〜30重量部のグリチルリ チンを含有するとともに、下記性状(1)および(2)を示すことを特徴とする 機能性食品用組成物。 (1)265〜275nm付近および305〜320nm付近に紫外部吸収を示 す。 (2)5w/v%水溶液にメタノール、エタノールまたはアセトンを加えたとき に白色の沈澱を生じる。 3.甘草水抽出液を乳酸醗酵させた後に醗酵液中の水分を除去して得た半固形な いし固形の物質からなり、イソリクイリチン1重量部に対して16〜500重量 部の乳酸および1/3〜30重量部のグリチルリチンを含有するとともに、下記 性状(1)および(2)を示すことを特徴とする機能性食品用組成物。 (1)水溶液にしたときに265〜275nm付近および305〜320nm付 近に紫外部吸収を示す。 (2)5w/v%水溶液にメタノール、エタノールまたはアセトンを加えたとき に白色の沈澱を生じる。 4.甘草水抽出液を乳酸醗酵させて得た醗酵液が、イソリクイリチン1重量部に 対して16〜500重量部の乳酸および1/3〜14重量部のグリチルリチンを 含有する、請求の範囲2または請求の範囲3に記載の機能性食品用組成物。 5.甘草水抽出液を乳酸醗酵させて得た醗酵液が、イソリクイリチン1重量部に 対して16〜500重量部の乳酸および1/3〜10重量部のグリチルリチンを 含有する、請求の範囲2〜請求の範囲4のいずれか1項に記載の機能性食品用組 成物。 6.醗酵液が、甘草水抽出液を1〜40℃の通性嫌気的状態の下に1日〜1年乳 酸醗酵させて得た液である、請求の範囲2〜請求の範囲5のいずれか1項に記載 の機能性食品用組成物。 7.甘草水抽出液が甘草の乾燥物の粉末の加熱抽出液である、請求の範囲2〜請 求の範囲6のいずれか1項に記載の機能性食品用組成物。 8.甘草水抽出液が、漢方薬に利用されている甘草エキスを水に溶解させて得た 溶液、または漢方薬に利用されている甘草粗エキスを水に懸濁させて得た懸濁液 である、請求の範囲2〜請求の範囲6に記載の機能性食品用組成物。 9.甘草が日本薬局方甘草末である、請求の範囲1〜請求の範囲7のいずれか1 項に記載の機能性食品用組成物。 10.醗酵物が実質的に甘くない、請求の範囲1に記載の機能性食品用組成物。 11.醗酵液が実質的に甘くない、請求の範囲2〜請求の範囲6に記載の機能性 食品用組成物。 12.請求の範囲1〜請求の範囲10のいずれか1項に記載の甘草抽出物を用い た機能性食品用組成物を含有することを特徴とする機能性食品。 13.請求の範囲11に記載の機能性食品において、前記機能性食品のベースと なる食品が水、清涼飲料および果実飲料からなる群より選択される1つである、 機能性食品。[Claims] 1. A functional food composition obtained by lactic acid fermentation of an extract obtained from a plant of the genus Glycyrrhiza. 2. A functional food composition comprising a fermentation broth obtained by lactic acid fermentation of an aqueous licorice extract, containing 16 to 500 parts by weight of lactic acid and 1/3 to 30 parts by weight of glycyrrhizin per part by weight of isoliquiritin, and exhibiting the following properties (1) and (2): (1) Exhibiting ultraviolet absorption in the vicinity of 265 to 275 nm and 305 to 320 nm. (2) Forming a white precipitate when methanol, ethanol, or acetone is added to a 5 wt% aqueous solution of the composition. 3. A functional food composition comprising a semi-solid or solid substance obtained by lactic acid fermentation of an aqueous licorice extract and subsequent removal of water from the fermentation broth, said composition containing 16 to 500 parts by weight of lactic acid and 1/3 to 30 parts by weight of glycyrrhizin per part by weight of isoliquiritin, and exhibiting the following properties (1) and (2): (1) When dissolved in water, it exhibits ultraviolet absorption in the vicinity of 265 to 275 nm and 305 to 320 nm. (2) When methanol, ethanol, or acetone is added to a 5 wt% aqueous solution, a white precipitate forms. 4. The functional food composition according to claim 2 or claim 3, wherein the fermentation broth obtained by lactic acid fermentation of an aqueous licorice extract contains 16 to 500 parts by weight of lactic acid and 1/3 to 14 parts by weight of glycyrrhizin per part by weight of isoliquiritin. 5. The functional food composition according to any one of claims 2 to 4, wherein the fermented liquor obtained by lactic acid fermentation of an aqueous licorice extract contains 16 to 500 parts by weight of lactic acid and 1/3 to 10 parts by weight of glycyrrhizin per part by weight of isoliquiritin. 6. The functional food composition according to any one of claims 2 to 5, wherein the fermented liquor is obtained by lactic acid fermentation of an aqueous licorice extract under facultative anaerobic conditions at 1 to 40°C for 1 day to 1 year. 7. The functional food composition according to any one of claims 2 to 6, wherein the aqueous licorice extract is a heated extract of dried licorice powder. 8. The functional food composition according to claims 2 to 6, wherein the licorice water extract is a solution obtained by dissolving a licorice extract used in herbal medicine in water, or a suspension obtained by suspending a crude licorice extract used in herbal medicine in water. 9. The functional food composition according to any one of claims 1 to 7, wherein the licorice is Japanese Pharmacopoeia licorice powder. 10. The functional food composition according to claim 1, wherein the fermented product is substantially unsweetened. 11. The functional food composition according to claims 2 to 6, wherein the fermented broth is substantially unsweetened. 12. A functional food comprising a functional food composition using the licorice extract according to any one of claims 1 to 10. 13. The functional food according to claim 11, wherein the base food of the functional food is one selected from the group consisting of water, soft drinks, and fruit drinks.
JP3512848A 1990-07-18 1991-07-18 Functional food composition using licorice extract Expired - Lifetime JP2801964B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3512848A JP2801964B2 (en) 1990-07-18 1991-07-18 Functional food composition using licorice extract

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18981090 1990-07-18
JP2-189810 1990-07-18
JP3512848A JP2801964B2 (en) 1990-07-18 1991-07-18 Functional food composition using licorice extract

Publications (2)

Publication Number Publication Date
JPWO1992001393A1 true JPWO1992001393A1 (en) 1992-08-06
JP2801964B2 JP2801964B2 (en) 1998-09-21

Family

ID=16247589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3512848A Expired - Lifetime JP2801964B2 (en) 1990-07-18 1991-07-18 Functional food composition using licorice extract

Country Status (6)

Country Link
US (1) US5264421A (en)
EP (1) EP0493611B1 (en)
JP (1) JP2801964B2 (en)
KR (1) KR0177832B1 (en)
DE (1) DE69128275T2 (en)
WO (1) WO1992001393A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42756E1 (en) 1990-03-13 2011-09-27 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6083220A (en) 1990-03-13 2000-07-04 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
ES2128270B1 (en) * 1997-09-04 2001-05-16 Arketa Zabala Aitor DRINK BASED DRINK.
JP2003026592A (en) * 2001-07-09 2003-01-29 Nippon Hypox Lab Inc Anti-androgenic agent comprising fermented licorice extract
JP2011001348A (en) * 2009-05-18 2011-01-06 Kaneka Corp Formulation for prevention or alleviation of alcohol drunkenness or hangover
CN103535709B (en) * 2012-07-09 2015-07-01 贾洪章 Healthcare food for chemical liver injury
JP6194412B2 (en) * 2013-04-29 2017-09-06 ハーシャ チグルパティ Toxicity reduction of alcoholic beverages
WO2016109509A1 (en) * 2014-12-31 2016-07-07 University of Central Oklahoma Formulation and process for making fermented probiotic food and beverage products
EP3307082B1 (en) * 2015-06-11 2022-08-31 System Biologie AG Composition for weight reduction comprising a beverage and beads
KR102212800B1 (en) 2019-02-13 2021-02-08 청운대학교산학협력단 Manufacturing method of fermented liquid of liquorice extract with increased amount of bioactive phytoestrogen and enriched calcium and the fermented liquid produced therefrom

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364034A (en) * 1964-03-09 1968-01-16 Swift & Co Method for removing characteristic flavor and/or odor from vegetable protein materials
JPS52130903A (en) * 1976-04-21 1977-11-02 Kunitarou Maruo Rubbing liquid of planttorigin
US4056637A (en) * 1976-06-08 1977-11-01 Japan Natural Food Co. Ltd. Process for preparing food products containing a lactic acid bacteria-fermented product of a cereal germ
JPS589652A (en) * 1981-07-06 1983-01-20 Miyasaka Koryo Kk Preparation of low calorific lactobacillus or lactic acid beverage and medicinal dring usink whey
US4626441B1 (en) * 1983-10-06 1991-02-19 Dietetic frozen desserts containing aspartame
JPS61286317A (en) * 1985-06-13 1986-12-16 Osaka Chem Lab Bathing agent
JPS6296428A (en) * 1985-10-24 1987-05-02 Kyoko Nakamura Refreshing drink containing plum component
JPH0763314B2 (en) * 1986-08-06 1995-07-12 加茂 恵子 Method for producing tea with ginseng extract
JPH06339547A (en) * 1993-06-01 1994-12-13 Fujita Corp Amusement device

Similar Documents

Publication Publication Date Title
JP3502587B2 (en) Sweetener composition containing high-purity arhat glycoside
US20010018090A1 (en) Calorie reducing agent
JPWO1992001393A1 (en) Functional food composition using licorice extract
KR20230104839A (en) Functional food composition containing the fermented natural extracts and the process for the preparation thereof
KR102214532B1 (en) health food composition using pomegranate fermented by lactic acid bacteria and manufacturing method thereof
JP2801964B2 (en) Functional food composition using licorice extract
KR101720051B1 (en) Pharmaceutical composition comprising fermented Aralia cordata Thunb for preventing or treating arthritis
KR101614929B1 (en) A pharmaceutical composition for treating cognitive and memory impairment
JP4589212B2 (en) Proanthocyanidin-containing food and process for producing the same
KR101482044B1 (en) Food composition comprising fermented product of Pleuropterus multiflorus and ginger for alleviating or preventing degenerative brain disorder and method of producing the same
KR20230001022A (en) A process for the preparation of sikhye containing lactobacillus and the sikhye containing lactobacillus prepared therefrom
KR101694617B1 (en) Method for Preparing of Undiluted Solution of Schizandra Extract or Undiluted Solution of Schizandra Extract Prepared by the Method
KR102042151B1 (en) A composition as a prebiotic for improving intestinal microflora containing extract from pepper leaves
KR20180042936A (en) a composition comprising the mycelium culture medium from Schizophyllum commune as an active ingredient for preventing or treating liver disease and alleviating hangover
KR20180117251A (en) Fermentative product of Sagunjatang having brain neuron cell-protective activity and uses thereof
KR102437419B1 (en) Composition for removing hangover
KR101034986B1 (en) Hangover relief composition containing mixed herbal extracts as an active ingredient
KR100527103B1 (en) Composition comprising microorganism having lipid metabolism-improving activity for prevention and treatement of geriatric diseases and the use thereof
JP4464082B2 (en) Muscle cell sugar transport enhancing composition containing mugwort as an active ingredient
KR102133473B1 (en) A composition as a prebiotic for improving intestinal microflora containing sweet potato vines
WO2007007994A1 (en) Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract
KR100848706B1 (en) Near water drinks with herbs
KR20220001317A (en) A composition comprising an extract of Phlomis umbrosa Turcz for treating and preventing hangover
KR102302047B1 (en) Composition for hepatoprotective and ameliorating hangover
KR100803385B1 (en) Neurological diseases prevention composition and food comprising horseradish extract